Coding Manual:
Hematopoietic Coding Manual (PDF)
Abstractor Notes
This code may be used for cases diagnosed prior to 1/1/2010.
Prior to 2010, Therapy-related myelodysplastic syndrome was categorized separately. In the 2008 WHO Manual, Therapy-related myeloid leukemia, Therapy-related myelodysplastic syndrome, and Therapy-related myelodysplastic/myeloproliferative neoplasms are grouped under 9920/3. This grouping reflects the fact that each of these neoplasms are caused by previous therapy and they are grouped in this manner to facilitate analysis.
For further information on the coding and abstracting of this neoplasm, see 9920/3.
Be aware that cases diagnosed prior to 2010 will be coded 9987/3.
Prior to 2010, Therapy-related myelodysplastic syndrome was categorized separately. In the 2008 WHO Manual, Therapy-related myeloid leukemia, Therapy-related myelodysplastic syndrome, and Therapy-related myelodysplastic/myeloproliferative neoplasms are grouped under 9920/3. This grouping reflects the fact that each of these neoplasms are caused by previous therapy and they are grouped in this manner to facilitate analysis.
For further information on the coding and abstracting of this neoplasm, see 9920/3.
Be aware that cases diagnosed prior to 2010 will be coded 9987/3.
Diagnostic Confirmation
None
Module Rule
None
Alternate Names
Therapy-related myelodysplastic syndrome (t-MDS), NOS (see 9920/3 for 2010+)
Therapy-related myelodysplastic syndrome, epipodophyllotoxin-related (see 9920/3 for 2010+)
Definition
Bone marrow failure that develops after treatment with chemotherapy or radiation therapy. There is no predominant cell type that is dysplastic, and the marrow aspirate is often inadequate to review for dysplasia, as the marrow is often hypocellular with fibrosis.
Therapy-related MDS arise as a result of cytotoxic chemotherapy and/or radiation therapy.
Therapy-related MDS arise as a result of cytotoxic chemotherapy and/or radiation therapy.
Definitive Diagnostic Methods
None
Genetics Data
None
Immunophenotyping
None
Treatments
Chemotherapy
Transformations to
There are no known transformations
Transformations from
There are no known transformations
Same Primaries
Corresponding ICD-10 Codes (Cause of Death codes only)
D46.7 Other myelodysplastic syndromes
Corresponding ICD-10-CM Codes (U.S. only)
D46.Z Other myelodysplastic syndromes (effective October 01, 2015)
Signs and Symptoms
Bone marrow failure
Cytopenia
Easy bruising or bleeding
Fatigue
Fever
Petechiae
Shortness of breath
Weakness
Weight loss or loss of appetite
Diagnostic Exams
Bone marrow biopsy or aspiration
CT (CAT) Scan
Cytogenetic analysis
Flow cytometry
Immunophenotyping
Lumbar puncture
Molecular analysis
Peripheral blood smear
Physical exam and history
Progression and Transformation
None
Epidemiology and Mortality
None
Sources
International Classification of Diseases for Oncology, 3rd edition (including revisions). Geneva: World Health Organization, 2001, 2011, 2020.
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Section: ICD-O-3.2 (2020) Morphological Codes
Pages: http://www.iacr.com.fr/index.php?option=com_content&view=category&layout=blog&id=100&Itemid=577
Home